Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 8-Week Trial of Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia

NCT04713878 is registered in ClinicalTrials.gov with Kanuni Sultan Suleyman Training and Research Hospital as lead sponsor.

NCT NCT04713878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 8-Week Trial of Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2020
Completion date
July 15, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19) pneumonia